This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

10 Stocks to Watch: Bank of America


NEW YORK ( TheStreet) -- Bank of America (BAC - Get Report) was flat at $13.12 in premarket trading Friday after reporting first-quarter earnings of 17 cents a share vs. the average analyst estimate of 27 cents a share.






Amylin Pharmaceuticals (AMLN) was surging 19.9% to $13.50 after the company, Eli Lilly (LLY) and Alkermes (ALKS) announced that European regulators have recommended the approval of an experimental type 2 diabetes treatment.






Infosys (INFY - Get Report) was falling 9.4% to $66.12 after India's No. 2 outsourcing software company said quarterly earnings rose almost 19% but came in below analysts' estimates.






Search giant Google (GOOG) was tumbling 5.5% to $547 as rising costs chipped away at profits in the latest quarter, causing the tech bellwether to come in 2 cents short of the average analysts' earnings estimate, despite strong revenue growth.






Natural gas producer Chesapeake Energy (CHK - Get Report) was falling 0.1% to $32.61 after agreeing to buy Bronco Drilling (BRNC) for about $315 million, including debt. Bronco shares were popping 5.8% to $11.






Drug companies Merck (MRK - Get Report) and Johnson & Johnson (JNJ - Get Report), and J&J subsidiary Centocor Ortho Biotech, have resolved a dispute over distribution rights to arthritis drugs Remicade and Simponi. Merck was rising 2.4% to $34.68 and J&J was unchanged at $60.02.






Toymaker Mattel (MAT - Get Report) said first-quarter revenue rose 8% but profits fell from a year earlier as costs increased.






Lexington, Mass.-based drug developer Cubist Pharmaceuticals (CBST) reported strong sales of its staph infection treatment Cubicin.

-- Written by Andrea Tse in New York.

Readers Also Like:

>>Bank of America Stock Not for Faint of Heart

>>8 Hot Cars Coming to N.Y. Auto Show

Copyright 2011 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BAC $15.39 -0.84%
CBST $101.94 0.14%
CHK $14.16 1.36%
GOOG $548.00 -0.73%
INFY $35.08 -1.96%

Markets

DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs